Loading...
Loading...
Loading...
Loading...
No reviews have been added for this product.
MBL Life Sciences
Monoclonal Antibody of 100 μg targeting Cyclin D1 for FCM, IHC, IP, WB.
| Product Specifications | |
| Application | FC, IP, WB, IHC |
| Reactivity | Human, Mouse |
| Clonality | Monoclonal IgG2a |
| Host | Mouse |
| Immunogen | Recombinant human PRAD1/cyclinD1 |
| Gene ID - Human | |
| Gene ID - Mouse | |
| Formulation | 100 μg IgG in 100 μl volume of PBS containing 50% glycerol, pH 7.2. No preservative is contained. |
| Storage | -20C |
| Documents & Links for Anti-Cyclin D1 (Human) mAb (Clone: 5D4) | |
| Datasheet | Anti-Cyclin D1 (Human) mAb (Clone: 5D4) Datasheet |
| Documents & Links for Anti-Cyclin D1 (Human) mAb (Clone: 5D4) | |
| Datasheet | Anti-Cyclin D1 (Human) mAb (Clone: 5D4) Datasheet |
| Citations for Anti-Cyclin D1 (Human) mAb (Clone: 5D4) – 1 Found |
| Bolidong, Dilireba; Domoto, Takahiro; Uehara, Masahiro; Sabit, Hemragul; Okumura, Tomoyuki; Endo, Yoshio; Nakada, Mitsutoshi; Ninomiya, Itasu; Miyashita, Tomoharu; Wong, Richard W; Minamoto, Toshinari. Potential therapeutic effect of targeting glycogen synthase kinase 3β in esophageal squamous cell carcinoma. Scientific Reports. 2020;10(1):11807. PubMed - Comments: Used in: WB |
MBL Life Sciences
Monoclonal Antibody of 100 μg targeting Cyclin D1 for FCM, IHC, IP, WB.
| Product Specifications | |
| Application | FC, IP, WB, IHC |
| Reactivity | Human, Mouse |
| Clonality | Monoclonal IgG2a |
| Host | Mouse |
| Immunogen | Recombinant human PRAD1/cyclinD1 |
| Gene ID - Human | |
| Gene ID - Mouse | |
| Formulation | 100 μg IgG in 100 μl volume of PBS containing 50% glycerol, pH 7.2. No preservative is contained. |
| Storage | -20C |
| Documents & Links for Anti-Cyclin D1 (Human) mAb (Clone: 5D4) | |
| Datasheet | Anti-Cyclin D1 (Human) mAb (Clone: 5D4) Datasheet |
| Documents & Links for Anti-Cyclin D1 (Human) mAb (Clone: 5D4) | |
| Datasheet | Anti-Cyclin D1 (Human) mAb (Clone: 5D4) Datasheet |
| Citations for Anti-Cyclin D1 (Human) mAb (Clone: 5D4) – 1 Found |
| Bolidong, Dilireba; Domoto, Takahiro; Uehara, Masahiro; Sabit, Hemragul; Okumura, Tomoyuki; Endo, Yoshio; Nakada, Mitsutoshi; Ninomiya, Itasu; Miyashita, Tomoharu; Wong, Richard W; Minamoto, Toshinari. Potential therapeutic effect of targeting glycogen synthase kinase 3β in esophageal squamous cell carcinoma. Scientific Reports. 2020;10(1):11807. PubMed - Comments: Used in: WB |
